biomedicina slovenica


"Medical Oncology" : 254-353

  1. Primic-Žakelj Maja
    Breast cancer prevention trials
    2000
  2. Žgajnar J; Gatzemeier W; Costa A
    Will the sentinel lymph node (SLN) stand a second time - SLN biopsy in breast cancer patients with isolated local recurrence following breast conserving therapy and previous SLN procedure
    2001
  3. Čufer T; Bračko M
    Myeloid metaplasia of the breast
    2001
  4. Furlan R; Auersperg M; Šoba E
    COMBINED MULTIDISCIPLINARY APPROACH TO ADVANCED T3-T4, N0-N3 SQUAMOUS CELL CARCINOMA OF ORAL CAVITY AND OROPHARYNX
    1981
  5. Ludwig Group; Orel J; Benedik M; Hrabar B; Ferluga D; Rott T
    INTRAPLEURAL CORYNEBACTERIUM PARVUM AS ADJUVANT THERAPY IN OPERABLE (STAGE 1 AND 2) BRONCHIAL NON-SMALL CELL CARCINOMA; PRELIMINARY REPORT
    1979
  6. Strojan Primož
    Postspecialistični študij na Peter MacCallum cancer institute, Melbourne
    2001
  7. Debevec Miha
    Onkologija 21. stoletja
    2000
  8. Golouh Rastko
    Uvodnik
    2000
  9. Debeljak Andrej; Triller Nadja; Kecelj Peter
    The role of flexible bronchoscopy in the localised peripheral lung tumours
    2000
  10. Kecelj Peter; Debeljak Andrej; Triller Nada; Kern I; Osolnik K; Šorli J
    Bronchoalveolar lavage in patients with lymphangiocarcinimatosis of the lung
    2000
  11. Šikić Branimir J; Šamija Mirko
    CEOC 2000. Program and abstract book of the 2nd central European oncology congress; 2000 Jun 27-30; Opatija
    2000
  12. Žakelj Bronja; Koporc Alenka
    Prihodnost Onkološkega inštituta kot izziv
    1995
  13. Čufer T
    Adjuvant therapy of breast cancer: update
    1999
  14. Primic-Žakelj M
    Screening mammography for early detection of breast cancer
    1999
  15. Ravnihar Božena
    Ob 50-letnici Onkološkega inštituta v Ljubljani: kratka zgodovina njegovega razvoja
    1988
  16. Snoj Marko
    Gradnja novega Onkološkega inštituta zastaja
    2000
  17. Zupanič-Slavec Zvonka
    Berta Jereb: zdravnica radioterapevtka onkologinja (1925): velika botra otroške onkologije
    [Berta Jereb: a pioneer of paediatric oncology]
    2000
  18. Zakotnik Branko
    Difficult decisions in medical oncology
    2000
  19. Ećimović Patricija
    Medical graduates in oncology
    2000
  20. Zwitter M; Ećimović P
    Advanced course on ethics in oncology: program and course material; 2000 Jun 25-28; Bled
    2000
  21. Anonymous ;
    Reading, writing and randomised trials - getting the most from publishing and publications. An ESMO course; 1999 Oct 27-30; Budapest
    1999
  22. Zwitter Matjaž
    Ethical considerations in publishing data and the ethics of the editorial process
    1999
  23. Tomšič Radka
    Prognostic factors in patients with non-Hodgkin's lymphoma of the head and neck in stage I and II
    1999
  24. Zabric Vida
    Pot k okrevanju - 15 let delovanja v Sloveniji
    1999
  25. Vegelj-Pirc Marija
    Psihoonkologija: 15 let delovanja Oddelka za psihoonkologijo na Onkološkem inštitutu Ljubljana
    1999
  26. Vegelj-Pirc Marija
    1984-1999 spremna beseda urednice zbornika
    1999
  27. Piškur-Kosmač Dunja
    Ob 15. obletnici Oddelka za psihoonkologijo in programa Pot k okrevanju
    1999
  28. Čufer T; Lazarev A; El-Ghamrawy K; Doval D; Vrba Z; Shah P; Kurtova A; Ghilezan N; Chalofti I; Blanc C
    Preliminary data of a phase II trial of taxotere (TXT) 100 or 75 mg/m2 as 2nd line chemotherapy (CT) in patients (pts) with metastatic breast cancer (MBC) with stratification according to prognosis factors
    1998
  29. Bambič Matevž
    Analiza odnosov v zdravstvu in na Onkološkem inštitutu
    1996
  30. Bambič Matevž
    Onkološki inštitut - strateško načrtovanje in management
    1996
  31. Karrer K; Eržen J; Hrabar B; Debevec M; Klevišar M; Rott T; et al ;
    The role of ifosfamide and cyclophosphamide in the multi-modality treatment after surgery for cure for small-cell bronchial carcinomas (SCLC)
    1989
  32. Goldhirsch A; Eržen D; Cerar O; Štabuc B; Golouh R; Lamovec J; Šebek S; Kramberger M; Vrhovec I
    Menstrual cycle and timing of breast surgery in premenopausal node-positive breast cancer: results of the International breast cancer study group (IBCSG) trial VI
    1997
  33. Stanovnik M; Čufer T; Borštnar S; Pajk B
    Clinical study with interferon alpha-2A and cis-retinoic acid (CRA) in metastatic cancer of the kidney
    1998
  34. Therasse P; Mauriac L; Welnicka M; Bruning P; Čufer T; Tomiak E; Curran D; Ramirez A; Koopmanschap M; Piccart M
    An EORTC-NCIC-SAKK neoadjuvant randomized phase III study comparing CEF (5FU, epirubicin, cyclophosphamide) vs dose intensified EC+G-CSF (filgrastim) in locally advanced breast cancer (LABC): updated results including quality of life
    1998
  35. Pajk B; Čufer T; Zakotnik B; Borštnar S; Us-Krašovec M
    DNA ploidy as a predictive factor of tamoxifen treatment in elderly breast cancer patients stage I-III
    1998
  36. Ocvirk J; Štabuc B; Čurin V; Žumec P
    Serum TNF-alpha and soluble TNF receptors p55 in melanoma patients
    1998
  37. Lindtner Jurij
    Spoštovana bralka, cenjeni bralec
    1998
  38. Rudolf Zvonimir
    Uvodnik
    1998
  39. Rudolf Zvonimir
    Oris Onkološkega inštituta: iz govora na svečani akademiji
    1999
  40. Rudolf Zvonimir; Čufer Tatjana; Kiauta Dušica; Kovač Vilijem; Serša Gregor
    Onkološki inštitut Ljubljana 60 let: 1938-1997: poročilo
    [Institute of oncology Ljubljana 60 years: 1938-1997: report]
    1998
  41. Kiauta Dušica; Bavec Marija; Podgoršek Milena; Štrukelj Breda; Tomšič Radka
    Bibliografija delavcev Onkološkega inštituta v Ljubljani 1993-1997
    [Bibliography of the staff of the Institute of oncology Ljubljana 1993-1997]
    1998
  42. Roth Anton
    In memoriam: prof. Krsto Kolarič
    1996
  43. Borisov Peter
    Docent dr. Josip Cholewa, prvi predstojnik Onkološkega inštituta v Ljubljani
    1998
  44. Golouh R
    Onkologija: uvodnik
    1997
  45. Raemaekers J; Burgers M; Henry-Amar M; Pinna A; Mandard A; Monfardini S; Hagenbeek A; Breed W; Carde P; Vovk M
    Patients with stage III/IV Hodgkin's disease in partial remission after MOPP/ABV chemotherapy have ecxellent prognosis after additional involved-field radiotherapy: interim results from the ongoing EORTC-LCG AND GPMC phase III trial
    1997
  46. Goldhirsch A; Gelber RD; Castiglione M; O'Neill A; Thurlimann B; Rudenstam C-M; Lindtner J; Collins J; Forbes J; Crivellari D
    Menstrual cycle and timing of breast surgery in premenopausal node-positive breast cancer: results of the International breast cancer study group (IBCSG) trial VI
    1997
  47. Snoj M
    Začetek gradnje Onkološkega inštituta
    1997
  48. Zupanič-Slavec Zvonka
    Cholewa, Josip, zdravnik kirurg in onkolog (slovenski zdravniki, nova gesla)
    1997
  49. Serša Gregor; Miklavčič Damijan
    Life sciences '97. Book of abstracts and programme of the International conference and the 2nd Slovenian-Croatian meeting on molecular oncology today; 1997 Oct 16-19; Gozd Martuljek
    1997
  50. Snoj Marko
    Začetek gradnje Onkološkega inštituta
    1997
  51. Budihna Marjan
    Izbrani problemi klinične onkologije v Sloveniji: možnosti za povečanje terapevtske učinkovitosti, zmanjšanje sopojavov in zmanjšanje invalidnosti: zaključno poročilo
    1996
  52. Noordijk EM; Carde P; Mandard AM; Mellink WAM; Monconduit M; Eghbali H; Tirelli U; Thomas J; Somers R; Vovk M
    Preliminary results of the EORTC-GPMC controlled clinical trial H7 in early-stage Hodgkin's disease
    1994
  53. Novak Ciril
    Psihodiagnostika v pripravljalnem postopku za oceno na invalidski komisiji
    1997
  54. Dšuban Gabrijela
    Dileme pri ocenjevanju delovne zmožnosti in ugotavljanju invalidnosti onkoloških bolnikov
    1997
  55. Dšuban Gabrijela; Čufer Tanja
    Zbornik prispevkov s strokovnega seminarja za zdravnike izvedence invalidskih komisij Zdravljenje in rehabilitacija onkološkega bolnika, psihofizične posledice zdravljenja ter pričakovani potek bolezni; 1997 maj 9; Ljubljana
    1997
  56. Antypas George
    Balkan congress of oncology; 1996 Jul 3-7; Athens
    1996
  57. Ocvirk J; Štabuc B; Volk N
    Serum cathepsin D in melanoma patients with metastatic melanoma
    1996
  58. Čufer T
    Mesto in vloga Onkološkega inštituta v programu "Slovenija 2000 in rak"
    1996
  59. Jereb B; Anžič J
    Pediatric oncology in Slovenia
    1996
  60. Fidler-Jenko Maria
    In memoriam Dr. Tatjana Šumi-Križnik
    1996
  61. Župančič Andrej O
    In memoriam dr. Jurij Stekar, zdravnik in kemik
    1996
  62. Kristančič S; Žličar A
    Obvladovanje stroškov na Onkološkem inštitutu v Ljubljani
    [Managing of expences at the Institute for oncology in Ljubljana]
    1996
  63. Petrič-Grabnar G; Jančar J; Zidar A; Vovk M
    Anaplastic large cell lymphoma - Hodgkin's like (ALCL-HL): clinical evaluation of 19 patients treated as Hodgkin's disease from 1982 to 1990
    1996
  64. Stucchi-Goldhirsch E; Forbes J; Price KN; Castiglione M; Gelber RD; Rudenstam C-M; Lindtner J; Collins J; Cavalli F; Cortes-Funes H
    Low-dose prednisone (p) in combination with adjuvant systemic therapy (AST) for operable breast cancer (BC) is associated with increased risk of second (non-breast) malignancies.
    1994
  65. Ravnihar B
    Ob jubileju onkološkega dispanzerja Mariborskega zdravstvenega doma
    [On the occasion of the jubilee of the oncological dispensary of the health home of Maribor]
    1989
  66. Židanik A
    Razmišljanja ob 25 - letnici gerontologije in onkološkega dispanzerja Zdravstvenega doma "dr. Adolfa Drolca" Maribor
    1989
  67. Bigec M; Lovrec R; Žnidaršič M
    Zbornik referatov 25. let gerontološkega in onkološkega dispanzerja
    1989
  68. Marini G; Murray S; Goldhirsch A; Gelber RD; Castiglione-Gertsch M; Price KN; Tattersall MHN; Rudenstam C-M; Collins J; Lindtner J
    The effect of adjuvant prednisone combined with CMF on patterns of relapse and occurence of second malignancies in patients with breast cancer
    1996
  69. Crivellari D; Price KN; Hagen M; Goldhirsch A; Gelber RD; Castiglione M; Coates AS; Rudenstam C-M; Collins J; Lindtner J
    Routine tests during follow-up of patients after primary treatment for operable breast cancer
    1995
  70. Rudolf Zvonimir
    Diagnostične metode v onkologiji - danes in jutri
    1996
  71. Fidler-Jenko M
    In memoriam dr. Tatjana Šumi-Križnik
    1996
  72. Skolnick AA
    Vojskovodja v boju proti raku se ozira v prihodnost: pogovor z dr. Vincentom T. DeVito ml.
    [Leader in war of cancer looks ahead: talking with Vincent T. DeVita, Jr, MD]
    1995
  73. Drinovec J
    Aktualni pogovor z dr. Metko Klevišar
    1995
  74. Karrer K; Denck H; Karnicka-Mlodkowska H; Drings P; Orel J; Salzer GM; Thermann M; Lattuneddu A; Sun Y; Hata E
    The role of ifosfamide and cyclophosphamide in the multi-modality treatment after surgery for cure for small-cell bronchial carcinomas (SCLC)
    1989
  75. Ravnihar B
    Onkološki inštitut
    1994
  76. Ravnihar B
    Onkologija
    1994
  77. Us-Krašovec M
    Prof. dr. Božena Ravnihar: her 80th anniversary
    1994
  78. Fras AP
    Onkologija
    1994
  79. Anonymous ;
    Onkološki inštitut v Ljubljani 55 let: 1938-1993
    [Institute of oncology Ljubljana 55 years: 1938-1993]
    1993
  80. Kiauta D; Bavec M; Podgoršek M; Serša G; Štrukelj B; Tomšič R
    Bibliografija delavcev Onkološkega inštituta v Ljubljani 1988-1992
    1993
  81. Huerny C; Lindtner J; Novak J; Eržen D; Senčar M; Červek J; Cerar O; Štabuc B; Golouh R; Lamovec J; Jančar J; Šebek S
    Timing of baseline quality of life assessment in an international adjuvant breast cancer trial: its effect on patient self-estimation
    1994
  82. Markovič S
    Ali slovenska medicina potrebuje interniste onkologe?
    [Does Slovene medicine need an internal medicine specialists-oncologists?]
    1993
  83. Spataro V; Price K; Goldhirsch A; Cavalli F; Simoncini E; Castiglione M; Rudenstam CM; Collins J; Lindtner J; Gelber RD
    Sequential estrogen receptor determinations from primary breast cancer and at relapse: prognostic and therapeutic relevance
    1992
  84. Benulič T; Serša G; Kovač V
    Advances in radiology and oncology
    1992
  85. Theuer W; Selawry O; Karrer K; Orel J; Eržen J; Hrabar B; Klevišar M; Debevec M; Rott T
    The impact of surgery on the multidisciplinary treatment of bronchogenic small cell carcinoma (updated review including ongoing studies)
    1992
  86. Boranić M
    Onkologija
    1991
  87. Goldhirsch A; Lindtner J; Novak J; Eržen D; Senčar M; Červek J; Cerar O; Štabuc B; Golouh R; Lamovec J; Jančar J; Šebek S
    The magnitude of endocrine effects of adjuvant chemotherapy for premenopausal breast cancer patients
    1990
  88. Ravnihar B
    Onkološko zdravstveno varstvo - boj proti raku
    1990
  89. Kiauta D
    Eden najbolje opremljenih INDOK centrov
    1991
  90. Štabuc B
    Model poslovnega sistema - Onkološki inštitut v Ljubljani
    1990
  91. Cerjak Z
    Realizacija integralnega informacijskega sistema
    1990
  92. Marolt F; Cerjak Z; Gaspari D; Jančar B; Škrk J; Štabuc B; Šuštaršič J; Vrhovec I; Žakelj M; Žličar A
    Idejni projekt za integralni informacijski sistem Onkološkega inštituta v Ljubljani
    1990
  93. Goldhirsch A; Lindtner J; Novak J; Naglas M; Červek J; Cerar O; Golouh R; Lamovec J; Jančar J; Šebek S
    Late effects of adjuvant oophorectomy and chemotherapy upon premenopausal breast cancer patients
    1990
  94. Rudolf Z
    Research activity at the Istitute of oncology in Ljubljana
    1990
  95. Rudolf Z
    Onkologija - problemi in perspektive
    [Oncology - problems and future prospects]
    1989
  96. Pompe-Kirn V; Primic-Žakelj M
    Upotreba epidemioloških metoda u ginekološkoj onkologiji
    1989
  97. Glaser E
    Separacija krvnih stanica u onkologiji
    [Cell separation in oncology]
    1987
  98. Nastran M
    Organizacija prehrane bolnikov na Onkološkem inštitutu v Ljubljani
    1987
  99. Plesničar S
    Onkološki inštitut - stremljenja in dosežki
    [The institute of oncology - endeavours and achievements]
    1986
  100. Lukas Irena
    Onkološki dispanzer v Mariboru
    1986

   1 54 154 254



New search      Comments      Top of page Institute for Biostatistics and Medical Informatics